Rates of myocardial infarction and coronary artery disease and risk factors in patients treated with radiation therapy for early-stage breast cancer

Cancer

Volumn 109, Issue 4, 2007, Pages 650-657

  Jagsi, Reshma ^a   Griffith, Kent A ^b   Koelling, Todd ^a   Roberts, Rachel ^a   Pierce, Lori J ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

Author keywords

Breast cancer; Breast conserving therapy; Cardiotoxicity; Coronary artery disease; Myocardial infarction; Radiation therapy

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; CORONARY RISK; DIABETES MELLITUS; EARLY CANCER; FOLLOW UP; HEART INFARCTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SMOKING;

ADULT; AGED; BREAST NEOPLASMS; CORONARY ARTERIOSCLEROSIS; HUMANS; INCIDENCE; MIDDLE AGED; MYOCARDIAL INFARCTION; NEOPLASM STAGING; RADIATION INJURIES; RADIOTHERAPY; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE;

EID: 33846912041     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22452     Document Type: Article

References (46)

1. Paszat LF, Mackillop WJ, Groome PA, et al. Mortality from myocardial infarction after adjuvant radiotherapy for breast cancer in the surveillance, epidemiology, and end-results cancer registries. J Clin Oncol. 1998;16:2625-2631.
2. Paszat LF, Mackillop WJ, Groome PA, et al. Mortality from myocardial infarction following postlumpectomy radiotherapy for breast cancer: a population-based study in Ontario, Canada. Int J Radiat Oncol Biol Phys. 1999;43:755-762.
3. Rutqvist LE, Lax I, Fornander T, et al. Cardiovascular mortality in a randomized trial of adjuvant radiation therapy versus surgery alone in primary breast cancer. Int J Radiat Oncol Biol Phys. 1992;22:887-896.
4. Rutqvist LE, Johansson H. Mortality by lateralty of the primary tumour among 55000 breast cancer patients from the Swedish Cancer Registry. Br J Cancer. 1990;61:866-868.
5. Cuzick J, Stewart H, Rutqvist L, et al. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol. 1994;12:447-453.
6. Early Breast Cancer Trialists' Collaborative Group. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Lancet. 2000;355:1757-1770.
7. Nixon AJ, Manola J, Gelman R, et al. No long-term increase in cardiac-related mortality after breast-conserving surgery and radiation therapy using modern techniques. J Clin Oncol. 1998;16:1374-1379.
8. Vallis KA, Pintilie M, Chong N, et al. Assessment of coronary heart disease morbidity and mortality after radiation therapy for early breast cancer. J Clin Oncol. 2002;20:1036-1042.
9. Giordano SH, Kuo YF, Freeman JL, et al. Risk of cardiac death after adjuvant radiotherapy for breast cancer. J Natl Cancer Inst. 2005;97:419-424.
10. Patt DA, Goodwin JS, Kuo YF, et al. Cardiac morbidity of adjuvant radiotherapy for breast cancer. J Clin Oncol. 2005;23:7475-7482.
11. Prosnitz RG, Marks LB. Radiation-induced heart disease: vigilance is still required. J Clin Oncol. 2005;23:7391-7394.
12. Harris EER, Correa C, Hwang WT, et al. Late cardiac mortality and morbidity in early-stage breast cancer patients after breast-conservation treatment. J Clin Oncol. 2006;24:4100-4106.
13. Woodward WA, Strom EA, McNeese MD, et al. Cardiovascular death and second non-breast cancer malignancy after postmastectomy radiation and doxorubicin-based chemotherapy. Int J Radiat Oncol Biol Phys. 2003;57:327-335.
14. Lamont EB, Christakis NA, Lauderdale DS. Favorable cardiac risk among elderly breast carcinoma survivors. Cancer. 2003;98:2-10.
15. Marks LB, Yu X, Prosnitz RG, et al. The incidence and functional consequences of RT-associated cardiac perfusion defects. Int J Radiat Oncol Biol Phys. 2005;63:214-223.
16. Pierce LJ, Griffith KA, Hayman JA, et al. Conservative surgery and radiotherapy for stage I/II breast cancer using lung density correction: 10-year and 15-year results. Int J Radiat Oncol Biol Phys. 2005;61:1317-1327.
17. Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med. 1997;337:949-955.
18. Overgaard M, Jensen MB, Overgaard J, et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet. 1999;353:1641-1648.
19. Ragaz J, Jackson SM, Le N, et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med. 1997;337:956-962.
20. National Hospital Discharge Survey. Available at URL: http://www.cdc.gov/nchs/about/major/hdasd/nhds.htm
21. United States Census. Available at URL: http://www.census.gov
22. Efron B, Tibshirani RJ. Monographs on Statistics and Applied Probability 57: An Introduction to the Bootstrap. Boca Raton, FL: Chapman & Hall/CRC; 1998.
23. Gyenes G, Gagliardi G, Lax I, Fornander T, Rutqvist LE. Evaluation of irradiated heart volumes in stage I breast cancer patients treated with postoperative adjuvant radiotherapy. J Clin Oncol. 1997;15:1348-1353.
24. Das IJ, Cheng EC, Freedman G, Fowble B. Lung and heart dose volume analyses with CT simulator in radiation treatment of breast cancer. Int J Radiat Oncol Biol Phys. 1998;42:11-19.
25. Pierce LJ, Moughan J, White J, Winchester DP, Owen J, Wilson JF. 1998-1999 patterns of care study process survey of national practice patterns using breast-conserving surgery and radiotherapy in the management of stage I-II breast cancer. Int J Radiat Oncol Biol Phys. 2005;62:183-192.
26. Cho BCJ, Schwartz M, Mijnheer BJ, Bartelink H. Simplified intensity-modulated radiotherapy using pre-defined segments to reduce cardiac complications in left-sided breast cancer. Radiother Oncol. 2004;70:231-241.
27. Krauss DJ, Kestin LJ, Raff G, et al. MRI-based volumetric assessment of cardiac anatomy and dose reduction via active breathing control during irradiation for left-sided breast cancer. Int J Radiat Oncol Biol Phys. 2005;61:1243-1250.
28. Sixel KE, Aznar MC, Ung YC. Deep inspiration breath hold to reduce irradiated heart volume in breast cancer patients. Int J Radiat Oncol Biol Phys. 2001;49:199-204.
29. Pedersen AN, Korreman S, Nystrom H, Specht L. Breathing adapted radiotherapy of breast cancer: reduction of cardiac and pulmonary doses using voluntary inspiration breathhold. Radiother Oncol. 2004;72:53-60.
30. Lu HM, Cash E, Chen MH, et al. Reduction of cardiac volume in left-breast treatment fields by respiratory maneuvers: a CT study. Int J Radiat Oncol Biol Phys. 2000;47:895-904.
31. Chen MH, Cash EP, Danias PG, et al. Respiratory maneuvers decrease irradiated cardiac volume in patients with left-sided breast cancer. J Cardiovasc Magn Reson. 2002;4:265-271.
32. Gladstone DJ, Flanagan MF, Southworth JB, et al. Radiation-induced cardiomyopathy as a function of radiation beam gating to the cardiac cycle. Phys Med Biol. 3004;49:1475-1484.
33. Darby SC, McGale P, Peto R. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol. 2005;6:557-565.
34. Rutqvist LE, Matteson A. Cardiac and thromboembolic morbidity among postmenopausal women with early stage breast cancer in a randomized trial of tamoxifen: the Stockholm Breast Cancer Study Group. J Natl Cancer Inst. 1993;85:1398-1406.
35. MacDonald CC, Alexander FE, Whyte BW, et al. Cardiac and vascular morbidity in women receiving adjuvant tamoxifen for breast cancer in a randomized trial. BMJ. 1995;311:977-980.
36. Constantino JP, Kuller LH, Ives DG, Fisher B, Dignam J. Coronary heart disease mortality and adjuvant tamoxifen therapy. J Natl Cancer Inst. 1997;89:776-782.
37. Reis SE, Constantino JP, Wickerham DL, et al. Cardiovascular effects of tamoxifen in women with and without heart disease: breast cancer prevention trial. J Natl Cancer Inst. 2001;93:16-21.
38. Barrett-Connor E, Grady D, Sashegyi A, et al. Raloxifene and cardiovascular events in osteoporotic postmenopausal women. Four-year results from the MORE (multiple outcomes of raloxifene evaluation) randomized trial. JAMA. 2002;287:847-857.
39. Beral V, Banks E, Reeves G. Evidence from randomised trials on the long-term effects of hormone replacement therapy. Lancet. 2002;360;942-944.
40. Braithwaite RS, Chlebowski RT, Lau J, et al. Meta-analysis of vascular and neoplastic events associated with tamoxifen. J Gen Intern Med. 2003;18:937-947.
41. Moschos SJ, Mantzoros CS. The role of the IGF system in cancer: from basic to clinical studies and clinical applications. Oncology. 2002;63:317-333.
42. Conti E, Marchese N, Andreotti F. Correspondence: favorable cardiac risk among elderly breast carcinoma survivors. Cancer. 2004;100:878-879.
43. Conti E, Pitocco D, Capuluongo E, et al. IGF-1 and macrovascular complications of diabetes. Diabetes Care. 2003;26:1653-1654.
44. Van den Beld AW, Bots ML, Janssen JA, Pols HA, Lamberts SW, Grobbee DE. Endogenous hormones and carotid atherosclerosis in elderly men. Am J Epidemiol. 2003;157:25-31.
45. Arciero TJ, Jacobsen SJ, Reeder GS, et al. Temporal trends in the incidence of coronary disease. Am J Med. 2004;117:228-233.
46. Goldberg RJ, Yarzebski J, Lessard D, Gore JM. A two-decades (1975 to 1995) long experience in the incidence, inhospital and long-term case-fatality rates of acute myocardial infarction: a community-wide perspective. J Am Coll Cardiol. 1999;33:1533-1539.